4121 Stock Overview
Rossmax International Ltd. develops and supplies healthcare products and solutions in Taiwan.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rossmax International Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$22.75 |
| 52 Week High | NT$36.85 |
| 52 Week Low | NT$22.00 |
| Beta | 0.60 |
| 1 Month Change | -12.50% |
| 3 Month Change | -5.01% |
| 1 Year Change | -18.17% |
| 3 Year Change | 9.64% |
| 5 Year Change | 108.72% |
| Change since IPO | -6.60% |
Recent News & Updates
Shareholder Returns
| 4121 | TW Medical Equipment | TW Market | |
|---|---|---|---|
| 7D | -4.0% | 0.3% | -0.6% |
| 1Y | -18.2% | 5.6% | 29.2% |
Return vs Industry: 4121 underperformed the TW Medical Equipment industry which returned 5.3% over the past year.
Return vs Market: 4121 underperformed the TW Market which returned 25.9% over the past year.
Price Volatility
| 4121 volatility | |
|---|---|
| 4121 Average Weekly Movement | 3.8% |
| Medical Equipment Industry Average Movement | 4.4% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in TW Market | 8.7% |
| 10% least volatile stocks in TW Market | 2.2% |
Stable Share Price: 4121 has not had significant price volatility in the past 3 months.
Volatility Over Time: 4121's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1988 | n/a | . Wendland | www.rossmax.com |
Rossmax International Ltd. develops and supplies healthcare products and solutions in Taiwan. The company offers activity monitor, a device for monitoring and tracking fitness-related metrics, such as distance walked or run, counting steps, and calories burned; body fat monitors that are used to measure body fat, body mass index, lean mass, muscle mass, and water ratio along with body weight; blood pressure monitors; sphygmomanometer, a device that measures blood pressure; stethoscope, an acoustic medical device for auscultation, or listening to the internal sounds; handheld pulse oximeter monitors to measure the amount of oxygen carried in the body; non-contact telephoto thermometers; and blood glucose monitoring system, a medical device for determining the approximate concentration of glucose in the blood. It also provides nebulizer, a drug delivery device used to administer medication; suction unit, a machine used to remove mucus and other bodily fluids; aero spacer, a device used to increase the ease of administering aerosolized medication; peak flow meter, a device used to monitor a person's ability to breathe out air; heating pad for therapy; and anti-decubitus mattresses.
Rossmax International Ltd. Fundamentals Summary
| 4121 fundamental statistics | |
|---|---|
| Market cap | NT$1.93b |
| Earnings (TTM) | -NT$6.66m |
| Revenue (TTM) | NT$3.81b |
0.5x
P/S Ratio-289.9x
P/E RatioIs 4121 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4121 income statement (TTM) | |
|---|---|
| Revenue | NT$3.81b |
| Cost of Revenue | NT$2.54b |
| Gross Profit | NT$1.27b |
| Other Expenses | NT$1.28b |
| Earnings | -NT$6.66m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.078 |
| Gross Margin | 33.42% |
| Net Profit Margin | -0.18% |
| Debt/Equity Ratio | 17.5% |
How did 4121 perform over the long term?
See historical performance and comparison